The DOI matches its Crossref record.
Progestin regulation of cellular proliferation.
Abstract
THE control of cellular proliferation is known to involve a delicate balance between the effects of different regulatory molecules including hormones and growth factors which provide, in the immediate environment of the cell, signals to stimulate or inhibit cellular replication (1). The past decade has seen significant progress in the identification and characterization of novel regulatory molecules, generally referred to as growth factors, and definition of their molecular mechanisms of action (2, 3). With the recent emphasis on peptide growth factors it is perhaps less well appreciated that some of the largest physiological changes (both positive and negative) in rates of growth and cell proliferation are mediated by steroid hormones. Recent studies on breast cancer cells (4) and immature rat uterus (5, 6), illustrating estrogenic control of autocrine and paracrine growth factor production, support the view that some of these steroid-induced responses are intimately linked to growth factor-mediated pathways although debate continues as to whether the growth factor response is the cause, or the consequence, of the estrogenic effect on cellular proliferation (7, 8). Generally speaking, the molecular mechanisms by which steroid hormones control proliferation are not well defined, with the most developed knowledge being in the area of estrogen action where a number of recent reviews are available (4, 9–11).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“recent data suggest that progestins exert a negative impact on breast cancer (2-5), with recent reports indicating an increased risk of the disease in women (6,7).”
Citations
Cited by
Sorted by citations
Items 101–200 of 660
Assisted Reproductive Techniques
Huang, J. Y. J., & Rosenwaks, Z. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0659-8_8 · Cited by 104
Carnevale, R. P., Proietti, C. J., Salatino, M., Urtreger, A. J., Peluffo, G., Edwards, D. P., Boonyaratanakornkit, V., Charreau, E. H., Joffé, E. B. D. K., Schillaci, R., et al. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0304 · Cited by 96
Vereide, A. B., Kaino, T., Sager, G., Arnes, M., & Ørbo, A. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.10.030 · Cited by 93
Use of PRKO Mice to Study the Role of Progesterone in Mammary Gland Development
Humphreys, R. C., Lydon, J. P., O’Malley, B. W., & Rosen, J. M. (1997) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1026343212187 · Cited by 92
Exploring the role of sex steroids through studies of receptor deficient mice
Couse, J. F., & Korach, K. S. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050244 · Cited by 92
“Progesterone has been traditionally defined as the “pregnancy hormone” in the mammal and is central to the coordinated development of the preimplantation embryo and the maternal uterus, ultimately leading to the establishment and maintenance of pregnancy [27].”
BackgroundIng, N. H., Beekman, J. M., Kessler, D. J., et al. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.12.2789 · Cited by 92
Effects of progestagens and Org OD14 in in vitro and in vivo tumor models
Kloosterboer, H. J., Schoonen, W. G. E. J., Deckers, G. H., et al. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90273-9 · Cited by 92
Jeong, J.-W., Lee, H. S., Lee, K. Y., White, L. D., Broaddus, R. R., Zhang, Y.-W., Vande Woude, G. F., Giudice, L. C., Young, S. L., Lessey, B. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903632106 · Cited by 92
“T ovarian steroid hormones progesterone (P4) and estrogen (E2) are essential regulators of reproductive events associated with all aspects involved in the establishment and maintenance of pregnancy (1, 2).”
BackgroundLiehr, J. G. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.97105s3565 · Cited by 91
“Progestin added to the estrogen medications does not inhibit mammary carcinogenesis (8) because the former hormone appears to be the primary mitogen of mammary ductal epithelial cells (9), whereas estrogen appears to function in”
BackgroundTangen, I. L., Werner, H. M. J., Berg, A., Halle, M. K., Kusonmano, K., Trovik, J., Høivik, E. A., Mills, G. B., Krakstad, C., & Salvesen, H. B. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.09.003 · Cited by 93
“Furthermore, progesterone induces differentiation of endometrial cells rendering them less sensitive to the effect of ER as well as other growth factors [40].”
BackgroundLabriola, L., Salatino, M., Proietti, C. J., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.3.1095-1111.2003 · Cited by 90
“Accumulated evidence also indicates that progestins are involved in controlling mammary tumorigenesis (9, 10, 13, 29, 35, 39, 43, 64).”
BackgroundGraham, J. D., Roman, S. D., McGowan, E. M., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.51.30693 · Cited by 90
Self-citationLiang, Y., Besch-Williford, C. L., Brekken, R. A., & Hyder, S. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1103 · Cited by 88
“The role of natural and synthetic progestins in the proliferation of breast tumor cells is controversial (1, 2).”
BackgroundExpression of the gene encoding growth hormone in the human mammary gland
Mol, J. A., Henzen-Logmans, S. C., Hageman, P., Misdorp, W., Blankenstein, M. A., & Rijnberk, A. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.10.7559904 · Cited by 94
Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer
Hamakawa, H., Nakashiro, K., Sumida, T., Shintani, S., Myers, J. N., Takes, R. P., Rinaldo, A., & Ferlito, A. (2008) · Head & Neck · doi:10.1002/hed.20830 · Cited by 86
Subnuclear Distribution of Progesterone Receptors A and B in Normal and Malignant Endometrium
Arnett-Mansfield, R. L., DeFazio, A., Mote, P. A., & Clarke, C. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031111 · Cited by 86
Self-citationAhola, T. M., Manninen, T., Alkio, N., & Ylikomi, T. J. (2002) · Endocrinology · doi:10.1210/en.2001-211445 · Cited by 86
“Progestins can regulate cell growth through autocrine and paracrine factors (30).”
BackgroundWen, D. X., Xu, Y., Mais, D. E., et al. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8356-8364.1994 · Cited by 86
“Both progesterone and estrogen are involved in the maintenance and development of female reproductive function and additionally are involved in the progression of hormone-dependent breast tumors (8).”
BackgroundInfluentialProgesterone receptor and the mechanism of action of progesterone antagonists
Edwards, D. P., Altmann, M., Marzo, A. M. D., et al. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00091-d · Cited by 85
The North American Menopause Society (2003) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200310020-00003 · Cited by 85
Energetic factors, ovarian steroids and the risk of breast cancer
Grazyna Jasienska, A., Thune, I., & Ellison, P. T. (2000) · European Journal of Cancer Prevention · doi:10.1097/00008469-200008000-00003 · Cited by 85
Plu‐Bureau, G., Lê, M. G., Sitruk-Ware, R. L., et al. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.291 · Cited by 84
Schoonen, W. G. E. J., Joosten, J. W. H., & Kloosterboer, H. J. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00215-4 · Cited by 84
Does the rat corpus luteum express the progesterone receptor gene?
Park-Sarge, O. K., Parmer, T. G., Gu, Y., et al. (1995) · Endocrinology · doi:10.1210/endo.136.4.7534703 · Cited by 84
Hild-Petito, S. A., Verhage, H. G., & Fazleabas, A. T. (1992) · Endocrinology · doi:10.1210/endo.130.4.1372241 · Cited by 83
Progesterone receptor A and B protein expression in human breast cancer
Graham, J. D., Yeates, C., Balleine, R. L., et al. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00226-x · Cited by 81
Self-citationARID1A Is Essential for Endometrial Function during Early Pregnancy
Kim, T. H., Yoo, J., Wang, Z., Lydon, J. P., Khatri, S., Hawkins, S. M., Leach, R. E., Fazleabas, A. T., Young, S. L., Lessey, B. A., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005537 · Cited by 79
“Stromalepithelial cross talk is critical in pregnancy [11,82] and P4 achieves inhibition of E2-induced epithelial cell proliferation by coordinating stromal-epithelial cross-talk [7,9,10].”
BackgroundRegulation of human endometrial function: mechanisms relevant to uterine bleeding
Critchley, H. O., Kelly, R. W., Baird, D. T., & Brenner, R. M. (2006) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-4-s1-s5 · Cited by 78
Lenhard, M., Lennerová, T., Heublein, S., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-553 · Cited by 78
“Progesterone is generally assumed to act antagonistically to oestrogen-mediated cell proliferation [11], though its specific role in OC is unknown.”
BackgroundPrior, J. C. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01777 · Cited by 80
“The “job” of E2 is to cause important cell growth that manifests as initial and continued cellular proliferation (8).”
BackgroundLiang, Y., & Hyder, S. M. (2005) · Endocrinology · doi:10.1210/en.2005-0103 · Cited by 76
“However, the role of progestins in breast cancer biology is controversial, and both proproliferative and antiproliferative effects have been described (14, 15, 38, 39).”
BackgroundResultCops, E. J., Bianco‐Miotto, T., Moore, N. L. T., Clarke, C. L., Birrell, S. N., Butler, L. M., & Tilley, W. D. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.10.014 · Cited by 76
Self-citationHormonal regulation of apoptosis and the Fas and Fas ligand system in human endometrial cells
Song, J. (2002) · Molecular Human Reproduction · doi:10.1093/molehr/8.5.447 · Cited by 76
“The growth, development and maintenance of the female sex organs involves a balance between the actions of the two major female sex steroids estradiol and progesterone (Clarke and Sutherland, 1990).”
BackgroundChalbos, D., & Galtier, F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31611-3 · Cited by 75
Non-Overlapping Progesterone Receptor Cistromes Contribute to Cell-Specific Transcriptional Outcomes
Clarke, C. L., & Graham, J. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035859 · Cited by 75
“Progesterone is critical for normal reproductive tissue function [23] and in the uterus supports differentiation, and inhibits proliferation [24].”
BackgroundSelf-citationAntiprogestins in breast cancer treatment: are we ready?
Lanari, C., Wargon, V., Rojas, P., & Molinolo, A. A. (2012) · Endocrine Related Cancer · doi:10.1530/erc-11-0378 · Cited by 75
“Moreover, while progestins were shown to exert a biphasic effect on breast cancer cells growing on plastic dishes (2D; reviewed in Clarke & Sutherland (1990)), they (MPA or progesterone) were clearly proliferative when these same cells grew in soft agar (Faivre & Lange 2007) or in 3D culture…”
BackgroundSaitoh, M., Ohmichi, M., Takahashi, K., Kawagoe, J., Ohta, T., Doshida, M., Takahashi, T., Igarashi, H., Mori-Abe, A., Du, B., et al. (2005) · Endocrinology · doi:10.1210/en.2004-1535 · Cited by 75
Bamberger, A., Milde‐Langosch, K., Schulte, H. M., et al. (2000) · Hormone Research in Paediatrics · doi:10.1159/000063434 · Cited by 75
“Since the human breast is one of the most important target organs for ovarian steroids [”
BackgroundReproductive functions of the progesterone receptor
Conneely, O. M. (2000) · Journal of the Society for Gynecologic Investigation · doi:10.1016/s1071-5576(99)00062-3 · Cited by 74
“Its effects are inhibited by progesterone (Clarke and Sutherland, 1990; Lydon et al., 1995).”
Molecular Oncology of Breast Cancer
Joshi, H. N., & Press, M. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35955-9.00022-2 · Cited by 85
Differential gene regulation by estrogen and progesterone in the primate endometrium
Ace, C. I., & Okulicz, W. C. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03674-v · Cited by 74
Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling
Singhal, H., Greene, M. E., Zarnke, A. L., Lainé, M., Abosy, R. A., Chang, Y.-F., Dembo, A. G., Schoenfelt, K. Q., Vadhi, R., Qiu, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21378 · Cited by 73
“For example, both PR agonists and antagonists inhibit estrogen-mediated growth of ER+/PR+ breast cancer models [17, 18].”
Bosschere, H. D., Ducatelle, R., Vermeirsch, H., et al. (2002) · Animal Reproduction Science · doi:10.1016/s0378-4320(02)00013-1 · Cited by 72
Mafuvadze, B., Liang, Y., Besch-Williford, C. L., et al. (2012) · Hormones and Cancer · doi:10.1007/s12672-012-0114-x · Cited by 72
“In vitro, progestins generally reduce the proliferation of human breast cancer cells [4].”
BackgroundEvolution of the human life cycle
Bogin, B., & Smith, B. H. (1996) · American Journal of Human Biology · doi:10.1002/(sici)1520-6300(1996)8:6
Molecular mechanisms of male germ cell differentiation
Hecht, N. B. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199807)20:7 · Cited by 434
CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin–proteasome
Zhang, P., Zhao, J., Li, H., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601602 · Cited by 71
“Upon progesterone treatment, T47D cells have an increase of S phase in the cell cycle (Clarke and Sutherland, 1990; Lange et al, 1999).”
BackgroundTodo, T., Ikeuchi, T., Kobayashi, T., et al. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01714-7 · Cited by 71
Johnson, M. L., Redmer, D. A., & Reynolds, L. P. (1997) · Biology of Reproduction · doi:10.1095/biolreprod56.2.393 · Cited by 71
“Progesterone effects on uterine growth have previously been thought to be antagonistic to estrogen, but more likely both steroids have modifying effects on each other and may even have synergistic growthpromoting effects in the uterus [4, 36].”
BackgroundInfluentialDahmoun, M., Boman, K., Cajander, S. B., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5706 · Cited by 71
“Interestingly, the temporal changes of apoptotic index and proliferation marker Ki-67 in stroma were close to the PR’s temporal changes and are in agreement with the studies showing the progesterone-induced second wave of proliferation in stroma late in the secretory phase ( 1 ).”
BackgroundResultInfluentialSwarbrick, A., Lee, C. S. L., Sutherland, R. L., & Musgrove, E. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2581-2591.2000 · Cited by 69
“The effects of progestins on cell proliferation are complex and display both cell and tissue specificity (6).”
BackgroundResultSelf-citationChristensen, S. A., Verhage, H. G., Nowak, G., de Lanerolle, P., Fleming, S. D., Bell, S. C., Fazleabas, A. T., & Hild-Petito, S. A. (1995) · Biology of Reproduction · doi:10.1095/biolreprod53.3.598 · Cited by 69
Progesterone receptors: various forms and functions in reproductive tissues
Sushama, G.-S. (2005) · Frontiers in bioscience · doi:10.2741/1685 · Cited by 68
Kurita, T., Medina, R. T., Schabel, A. B., Young, P., Gama, P., Parekh, T. V., Brody, J. R., Cunha, G. R., Osteen, K. G., Bruner‐Tran, K. L., et al. (2005) · Differentiation · doi:10.1111/j.1432-0436.2005.00033.x · Cited by 67
Frost, R. A., Mazella, J., & Tseng, L. (1993) · Biology of Reproduction · doi:10.1095/biolreprod49.1.104 · Cited by 68
Wagner, B. L., Pollio, G., Giangrande, P. H., Webster, J. C., Breslin, M. B., Mais, D. E., Cook, C. E., Vedeckis, W. V., Cidlowski, J. A., & McDonnell, D. P. (1999) · Endocrinology · doi:10.1210/endo.140.3.6581 · Cited by 71
Expression Profiling of Human Breast Cancers and Gene Regulation by Progesterone Receptors
Jacobsen, B. M., Richer, J. K., Sartorius, C. A., & Horwitz, K. B. (2003) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000010028.48159.84 · Cited by 65
“Endogenous progesterone appears to have similar effects, as demonstrated by studies showing that breast epithelial mitoses peak in the late luteal phase (51).”
Goodwin, J. W., Green, S., Moinpour, C. M., Bearden, J. D., Giguere, J. K., Jiang, C. S., Lippman, S. M., Martino, S., & Albain, K. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.6179 · Cited by 65
“Studies both in vitro and in vivo have demonstrated both stimulating and inhibitory properties of progestins on breast epithelium.(17,18) Data from the Woman’s Health Initiative study and review reports(19-22) demonstrate an increased risk of breast cancer from estrogen plus progesterone as compared with estrogen alon…”
BackgroundVallejo, G., Ballaré, C., Barañao, J. L., Beato, M., & Saragüeta, P. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0016 · Cited by 64
“In the uterus, estrogen stimulates proliferation of the endometrial epithelium, whereas progesterone is the essential stimulus needed for in vivo proliferation of stromal cells and acts as the switch for their specific decidual program (2, 3).”
Influence of sex steroids on inflammation and bone metabolism
Shiau, H. J., Aichelmann‐Reidy, M. E., & Reynolds, M. A. (2013) · Periodontology 2000 · doi:10.1111/prd.12033 · Cited by 65
Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women
Balleine, R. L., Earl, M. J., Greenberg, M. L., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690249 · Cited by 64
“Proge down-regulation of ER and inhibition of oestrogenic activity also been demonstrated convincingly in cultured breast ca cells (Clarke and Sutherland, 1990).”
BackgroundSelf-citationHypermethylation can selectively silence multiple promoters of steroid receptors in cancers
Sasaki, M., Kaneuchi, M., Fujimoto, S., Tanaka, Y., & Dahiya, R. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(03)00084-4 · Cited by 64
Mammographic density changes during different postmenopausal hormone replacement therapies
Şendağ, F., Terek, M. C., Özşener, S., et al. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01935-5 · Cited by 64
Zhang, D., Zhang, X., Michel, F. J., et al. (2002) · Endocrinology · doi:10.1210/endo.143.1.8590 · Cited by 63
Lin, V. C. L., Ng, E. H., Aw, S. E., et al. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.3.0426 · Cited by 63
“effects of progestins in T47D cells (1) and in a PR-”
BackgroundTriclosan and bisphenol a affect decidualization of human endometrial stromal cells
Forte, M., Mita, L., Cobellis, L., Merafina, V., Specchio, R., Rossi, S., Mita, D. G., Mosca, L., Castaldi, M. A., Falco, M. D., et al. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.11.017 · Cited by 62
“Most of these modifications are regulated by the cyclic equilibrium of estrogen and progesterone levels (Martin, 1980; Clarke and Sutherland, 1990).”
BackgroundOECD (2012) · OECD series on testing and assessment · doi:10.1787/9789264221352-en · Cited by 63
Association of progesterone receptor polymorphism with recurrent abortions
Schweikert, A., Rau, T., Berkholz, A., et al. (2004) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2003.04.002 · Cited by 62
“Progesterone is involved in the control of gonadotropin secretion, it is required for the implantation of the embryo, it promotes uterine growth and suppresses myometrical contractility [4–6].”
BackgroundEffects of sex steroids on proliferation in normal mammary tissue
Söderqvist, G. (1998) · Annals of Medicine · doi:10.3109/07853899809002598 · Cited by 63
Chaffkin, L. M., Luciano, A. A., & Peluso, J. J. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.3.8445028 · Cited by 61
A double-blind randomized study on the effects of red clover isoflavones on the endometrium
Hale, G. E., Hughes, C. L., Robboy, S. J., Agarwal, S. K., & Bievre, M. (2001) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200109000-00008 · Cited by 61
“This is surprising in view of the potent antiproliferative action of progesterone via induction of estradiol dehydrogenase,(29) a decrease in ER messenger ribonucleic acid transcription, and induction of various antiproliferative growth factors.(30) During the proliferative phase of the normal human menstrual cycle, K…”
BackgroundJohnson, M. L., Redmer, D. A., & Reynolds, L. P. (1997) · Biology of Reproduction · doi:10.1095/biolreprod57.3.588 · Cited by 61
Oocyte selection of mutations affecting cytoplasmic polyadenylation of maternal mRNAs
Verrotti, A. C., & Strickland, S. (1997) · Molecular Reproduction and Development · doi:10.1002/(sici)1098-2795(199704)46:4 · Cited by 10
Progestin Regulation of Estrogen Receptor Messenger RNA in Human Breast Cancer Cells
Alexander, I. E., Shine, J., & Sutherland, R. L. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-6-821 · Cited by 60
Self-citationButt, A. J., Caldon, C. E., McNeil, C. M., Swarbrick, A., Musgrove, E. A., & Sutherland, R. L. (2008) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-78818-0_12 · Cited by 59
Self-citationLin, V. C. L., Ng, E. H., Aw, S. E., et al. (1999) · PubMed · Cited by 59
Akahira, J., Inoue, T., Suzuki, T., Ito, K., Konno, R., Sato, S., Moriya, T., Okamura, K., Yajima, A., & Sasano, H. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1463 · Cited by 59
“The biological role of progesterone in epithelial ovarian carcinoma is unknown, but progesterone is, in general, considered to function antagonistically to oestrogen-mediated cell proliferation (Clarke and Sutherland, 1990).”
BackgroundProgesterone receptor regulation by retinoic acid in the human breast cancer cell line T-47D.
Clarke, C. L., Roman, S. D., Graham, J. D., Koga, M., & Sutherland, R. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38400-5 · Cited by 59
Self-citationPostmenopausal hormone therapy and breast cancer
Speroff, L. (1996) · Obstetrics and Gynecology · doi:10.1016/0029-7844(95)00428-9 · Cited by 57
Papa, V., Hartmann, K. K. P., Rosenthal, S. M., Maddux, B. A., Siiteri, P. K., & Goldfine, I. D. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-5-709 · Cited by 59
“Progestins have a variety of metabolic and proliferative effects on breast cancer cells (16,17).”
BackgroundHamilton, J. A., Callaghan, M. J., Sutherland, R. L., et al. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.4.9909 · Cited by 58
Self-citationCoexistence of Intracellular and Membrane-Bound Progesterone Receptors in Human Testis
Shah, C., Modi, D. N., Sachdeva, G., Gadkar, S., & Puri, C. P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0793 · Cited by 58
Prevention of bone loss by EM-800 and raloxifene in the ovariectomized rat
Martel, C., Picard, S., Richard, V., Bélanger, A., Labrie, C., & Labrie, F. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00087-x · Cited by 57
“It should be mentioned that recent data suggest that not only estrogens but also progestins can have a negative impact on breast cancer [8,9,40,41].”
BackgroundEstrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells.
Jeng, M. H., Langan-Fahey, S. M., & Jordan, V. C. (1993) · Endocrinology · doi:10.1210/endo.132.6.8504763 · Cited by 57
Graham, J., Sm, H., Tran, N. T., et al. (1999) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0220295 · Cited by 56
“The general chemicals used were of molecular biological or analytical reagent grade, as required by specific methodology, and were from the same sources as previously listed (Clarke et al. 1990).”
MethodSelf-citationAbd‐Elkareem, M. (2017) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2017.03.007 · Cited by 56
“These include ovulation, growth and differentiation of ovarian structures, uterine and mammary gland development, pregnancy establishment and maintenance and the neuro-behavioral expression associated with sexual responsiveness (Clarke and Sutherland, 1990; Lydon et al., 1995; Pinter et al., 1996; Conneely et al., 200…”
BackgroundMusgrove, E. A., Hunter, L.-J. K., Lee, C. S. L., Swarbrick, A., Hui, R., & Sutherland, R. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106371200 · Cited by 55
Self-citationZaveri, N. T., & Murphy, B. J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00063-8 · Cited by 59
Distribution of estrogen and progesterone receptors isoforms in endometrial cancer
Kreizman-Shefer, H., Pricop, J., Goldman, S., et al. (2014) · Diagnostic Pathology · doi:10.1186/1746-1596-9-77 · Cited by 55
“The physiological roles of progesterone in the regulation of endometrial tissue are, in general, considered to antagonize estrogen-mediated cell proliferation and to induce cellular differentiation [14,15].”
BackgroundOestrogen and progesterone receptors in feline fibroadenomatous change: an immunohistochemical study
Mulas, J. M. D. L., Millán, Y., Bautista, M. J., et al. (2000) · Research in Veterinary Science · doi:10.1053/rvsc.1999.0327 · Cited by 55
Miki, Y., Clyne, C. D., Suzuki, T., Moriya, T., Shibuya, R., Nakamura, Y., Ishida, T., Yabuki, N., Kitada, K., Hayashi, S., et al. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.11.038 · Cited by 55
“It is well-known that progesterone inhibits cellular proliferation through PR [41], and administration of progestins is currently performed as an endocrine therapy in breast carcinoma patients [3], although some controversies exist with respect to progesterone actions in breast carcinoma [41,42].”
BackgroundGass, E. K., Leonhardt, S. A., Nordeen, S. K., et al. (1998) · Endocrinology · doi:10.1210/endo.139.4.5944 · Cited by 55
“Additionally, progesterone is implicated in the development and progression of breast and uterine malignancies (1, 2).”
BackgroundRoles of Estrogen and Progesterone in Normal Mammary Gland Development
Shyamala, G. (1997) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(96)00207-x · Cited by 58
Immunocytochemical Localization of Sex Steroid Hormone Receptors in Normal Human Mammary Gland
Li, S., Han, B., Liu, G., Li, S., Ouellet, J., Labrie, F., & Pelletier, G. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.954644 · Cited by 56
“The twoPR receptors are transcribed from the samegene, throughalternative promoter usage (Clarke and Sutherland 1990).”
BackgroundProgesterone receptor is not required for progesterone action in the rat corpus luteum of pregnancy☆
Telleria, C. M., Stocco, C. O., Stati, A. O., & Deis, R. P. (1999) · Steroids · doi:10.1016/s0039-128x(99)00061-6 · Cited by 55
New insights into estrogen receptor function in human breast cancer
Murphy, L., Cherlet, T., Lewis, A., Banu, Y., & Watson, P. (2003) · Annals medicus · doi:10.1080/07853890310014579 · Cited by 57
Verhaar, H. J. J., Damen, C. A., Duursma, S. A., et al. (1994) · Bone · doi:10.1016/8756-3282(94)90293-3 · Cited by 54
Role of Epigenomics in Ovarian and Endometrial Cancers
Balch, C., Matei, D. E., Huang, T. H. ‐., & Nephew, K. P. (2010) · Epigenomics · doi:10.2217/epi.10.19 · Cited by 52
Induction of Overt Menstruation in Intact Mice
Rudolph, M., Döcke, W., Müller, A., Menning, A., Röse, L., Zollner, T. M., & Gashaw, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032922 · Cited by 52
“The growth activity of stroma cells is elevated in both the proliferative phase and the late secretory phase of the menstrual cycle, whereby the latter is induced by progesterone in a second wave of proliferation [21,22].”
BackgroundA complex role for the progesterone receptor in the response to vascular injury
Karas, R. H., van Eickels, M., Lydon, J. P., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200111374 · Cited by 53
Metadata
- Authors
- CLARKE, C. L., & SUTHERLAND, R. L.
- Affiliations
- Garvan Institute of Medical Research (AU)
- Corresponding author
- SUTHERLAND, ROBERT L.
- ORCID
- CLARKE, CHRISTINE L.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1990-05
- Volume
- 11
- Issue
- 2
- Pages
- 266-301
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2056357500
- Cited by
- 650
- References
- 0
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 4 · 2022: 9 · 2021: 7 · 2020: 5 · 2019: 7 · 2018: 6 · 2017: 10 · 2016: 12 · 2015: 18 · 2014: 12 · 2013: 15 · 2012: 21
- FWCI
- 10.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- progestins, cell proliferation, steroid hormones, growth factors, estrogen, breast cancer cells, immature uterus, autocrine and paracrine signaling, cell cycle regulation
- MeSH terms
- Animals, Haplorhini, Cell Division, Chickens, Humans, Progestins, Rabbits, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review